Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma Feature in Positive Magazine

The CEO of Bionor Pharma, Anker Lundemose is interviewed in this article about the AIDS conference in Kuala Lumpur July 2013. 

Dr. Lundemose emphasizes the Danish HIV research aiming at emptying the HIV reservoirs in the body, which potentially can contribute to a Functional Cure for HIV.

 

HivNorge is a Norwegian organization based in Oslo, for people living with HIV. Their main objectives are to take care of rights and interests of HIV-positive people in the society, to work for a better understanding of their situation, and to combat fear, prejudice and discrimination. Their magazine Positive has in this article focused on the AIDS Conference in Kuala Lumpur July 2013, and the new recommendations from WHO (World Health Organization).

 

See more at the Bionor Pharma website.

Associated companies:


Related news

Latest news

Eimskip strengthens its worldwide forwarding services by acquiring the logistics company SHIP-LOG A/S in Denmark

Eimskip has strengthened its position in worldwide logistics services by acquiring 75% of the freight forwarding company SHIP-LOG. 

For Sale Assets from the former BMV LAKSEVÄG YARD in Bergen, Norway!

For Sale Assets from the former BMV LAKSEVÄG YARD in Bergen, Norway! The entire shipbuilding and fabricating facility is closing and more than 500 lots is on sale.

Servogear CPP for Seasight II - Future of the Fjords

We are proud to announce that Servogear has been chosen for the delivery of Servogear...

TechnipFMC Signs Agreement with Pall to Supply Slurry Oil Filtration Systems for Fluid Catalytic Cracking Units

The associated activities will be managed by TechnipFMC Process Technology’s center in Houston,

10 Million kroner for verification funding

The Norwegian Research Council has granted 10 million...

Hilti acquires Oglaend System Group

Oglaend System’s headquarters will remain in Klepp, 

DOF Subsea AS ("DOF Subsea" or the "Company") today announces its intention to launch an initial public offering (the "IPO") of its ordinary shares and to apply for a listing on Oslo Børs

NOT FOR DISTRIBUTION OR RELEASE,

DOF Subsea North America extends charter for Jones Act Compliant vessel Harvey Deep Sea

The Harvey Deep Sea Vessel is a Multi-Purpose DPII Construction,

Untrue rumours about an on-going incident at the Halden Research Reactor in Norway

The Norwegian Radiation Protection Authority has become aware that stories about an ongoing incident involving a “meltdown” at the Norwegian Institute for Energy Technology (IFE) reactor situated in Halden are currently ci...